Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron Isomaltoside vs Ferrous Succinate in PD Patients with Renal Anemia
NCT06830941Phase 4Not yet recruiting
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Modality
- Inorganic Nanoparticles, Small Molecules
01
Overview
A Phase 4 trial of ferric derisomaltose in anemia of chronic kidney disease. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
ferric derisomaltose
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT06830941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06830941.